Visionary Holdings: Generative AI Leads the Efficiency Revolution, Reshaping the Future of FinTech and Biotechnology

Rhea-AI Summary

Visionary Holdings (GV) has demonstrated significant achievements in implementing generative AI across FinTech and biotechnology sectors. The company's AI solutions have delivered notable improvements in their digital asset trading platform, including a 40% reduction in transaction delays and a 97.5% fraud detection rate.

In their FinTech operations, AI implementation has reduced labor costs by 40% while increasing customer satisfaction to 94.2%. Their biotechnology division has achieved a 98.7% sensitivity rate in AI-driven cervical cancer E7 protein detection, earning FDA certification.

The company's AI system operates on a four-layer architecture: Intelligent Perception, Cognitive Decision, Generative Execution, and Autonomous Evolution, enabling comprehensive solutions across financial and medical applications. According to IDC, AI is projected to contribute $19.9 trillion to the global economy by 2030, representing 3.5% of global GDP.

Positive

• 40% reduction in transaction processing delays
• 97.5% fraud detection rate in financial operations
• 40% reduction in customer service labor costs
• 94.2% customer satisfaction rate
• 98.7% sensitivity rate in cancer detection with FDA certification

Negative

• None.

TORONTO, Feb. 28, 2025 /PRNewswire/ -- In the context of the global economy's digital transformation, Artificial Intelligence (AI) has emerged as a pivotal force driving productivity growth. According to IDC's latest report, AI is expected to contribute up to $19.9 trillion to the global economy by 2030, equivalent to 3.5% of the global GDP. Among these advancements, Generative AI, with its ability to produce creative outputs, is ushering in the fourth productivity revolution—following the eras of the steam engine, electricity, and computers. As a Nasdaq-listed company (Stock Code: GV), Visionary Holdings has emerged as a leader in this technological transformation, achieving groundbreaking progress in FinTech, digital currencies, and biotechnology through deep research and development in generative AI.

In the FinTech and digital currency sectors, traditional operational models face numerous challenges, particularly in transaction processing delays and risk control compliance. The high volatility of the digital currency market makes it difficult for traditional matching engines to handle massive orders during peak trading periods, causing delays that severely impact investor decision-making. At the same time, increasingly stringent global regulatory policies require FinTech companies to monitor abnormal transactions in real time, a task for which traditional risk control systems are often inadequate.

Visionary Holdings' generative AI technology has successfully addressed these challenges. On its digital asset trading platform, AI technology has optimized the matching engine, reducing transaction delays by 40% and significantly improving execution speed. Advanced machine learning models have achieved a fraud detection rate of 97.5%, effectively mitigating risks such as money laundering and hacker attacks. Additionally, AI-powered deep analysis provides users with personalized investment advice and optimal trading strategies, enhancing profitability. Furthermore, the implementation of AI customer service has reduced labor costs by 40% while increasing customer satisfaction to 94.2% (2023 operational data), significantly improving service quality.

The biotechnology sector also faces challenges, such as the complexity of medical data processing and the difficulty of meeting personalized healthcare needs. Traditional data analysis methods are inefficient in handling data from gene sequencing, cancer screening, and biochips, while limited medical resources hinder the development of precise, personalized treatment plans. Visionary Holdings' AI technology offers solutions to these issues. In cancer screening and genetic testing, the AI-driven analysis of biochip data for cervical cancer E7 protein detection has achieved a sensitivity rate of 98.7% and has received FDA certification. In intelligent drug development, AI accelerates the screening of new drugs by analyzing cancer patients' genetic data, improving drug matching rates and bringing breakthroughs in precision medicine.

Visionary Holdings' intelligent AI system employs a unique four-layer architecture to ensure efficient and intelligent management. The Intelligent Perception Layer supports multimodal inputs such as voice, text, market data, and biochip data, providing real-time investment and medical diagnostic recommendations through AI analysis. The Cognitive Decision Layer includes an intelligent risk control engine and a medical knowledge graph, enabling real-time financial risk monitoring and the generation of precise medical solutions. The Generative Execution Layer features AI trading assistants and health assistants, offering practical support services to users and patients. The Autonomous Evolution Layer uses reinforcement learning loops and human feedback optimization to continuously improve AI model accuracy, ensuring recommendations comply with regulatory and medical standards.

Looking ahead, the prospects for AI technology are vast. Visionary Holdings will continue to lead industry trends by promoting AI-driven financial compliance management, using natural language understanding to automatically adapt to financial regulations across countries and reduce compliance costs. Additionally, the company will explore the integration of quantum computing and AI to enable more complex financial modeling and medical data analysis, further enhancing predictive capabilities.

With the rapid advancement of AI technology, the global industry is expected to enter a new era of intelligence in 2024. Visionary Holdings, through its exceptional practices in generative AI, has not only achieved significant growth for its own business but also provided valuable insights for industry development, guiding the FinTech and biotechnology sectors toward a smarter and more efficient future.

For more information, please contact:
Visionary Holdings Inc.
Investor Relations Department
Email: ir@farvision.ca

View original content:https://www.prnewswire.com/news-releases/visionary-holdings-generative-ai-leads-the-efficiency-revolution-reshaping-the-future-of-fintech-and-biotechnology-302383388.html

SOURCE Visionary Holdings Inc.

FAQ

What performance improvements has GV's AI technology achieved in their digital trading platform?

GV's AI technology reduced transaction delays by 40% and achieved a 97.5% fraud detection rate on their digital asset trading platform.

How successful is GV's AI technology in cancer detection?

GV's AI-driven analysis for cervical cancer E7 protein detection achieved a 98.7% sensitivity rate and received FDA certification.

What cost savings has GV realized through AI implementation in customer service?

GV reduced labor costs by 40% while increasing customer satisfaction to 94.2% through AI customer service implementation.

What are the four layers of GV's AI architecture system?

GV's AI system consists of Intelligent Perception Layer, Cognitive Decision Layer, Generative Execution Layer, and Autonomous Evolution Layer.

How much is AI expected to contribute to the global economy by 2030 according to IDC?

According to IDC, AI is expected to contribute $19.9 trillion to the global economy by 2030, equivalent to 3.5% of global GDP.